How about comparing apples and apples...not oranges...was the drug already developed...did it have a patent...were the trials over....3.64 to 31.00 doesn't happen when something has had none of the heavy lifting done...and is based on science that is for the most part unproven....
The company has been very shady revealing next to nothing about their miracle pill except saying things like TLR..Top Line Results...well what were they?
The creme has efficacy (phase one) behind it..that's all..so it won't kill anyone....
Does it work?
And for all the diseases it's touted for...there is absolutely no clinical evidence or peer reviewed science at this point to support anything...
Me too! Bought in at $.75 and it was bought for $8/sh, I sold at $8.50/sh. Overnight penny stock drug company with heavy debt, no revenues, and no patent granted. The Phase II positive results was the catalyst for the new drug application.
News 
Market Data 
Discover 
AI
